Literature DB >> 21925073

Adrenocortical (dys)function in septic shock - a sick euadrenal state.

Bala Venkatesh1, Jeremy Cohen.   

Abstract

A central feature of the endocrine pathophysiology of septic shock is thought to be the existence of adrenal dysfunction. Based on changes in glucocorticoid secretion and responsiveness, protein binding, and activity. These changes have been described by the terms "Relative Adrenal Insufficiency" (RAI), or "Critical Illness Related Corticosteroid Insufficiency" (CIRCI), and form part of the rationale for trials of glucocorticoid treatment in septic shock. Diagnostic criteria for these conditions have been based on plasma cortisol profiles and have proven notoriously difficult to establish. The uncertainty in this area arises from the inability of current tests to clearly identify who is truly glucocorticoid "deficient" at a cellular level, and hence who requires supplemental glucocorticoid administration. Emerging data suggest that there may be abnormalities in the tissue activity of glucocorticoids in patients with severe sepsis and plasma profiles may not be reliable indicators of tissue glucocorticoid activity, We put forward an alternative point of view, that is the spectrum of adrenocortical dysfunction in sepsis - plasma and tissue, can be grouped under the umbrella of a "sick euadrenal syndrome" rather than an adrenocortical insufficiency.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925073     DOI: 10.1016/j.beem.2011.04.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  8 in total

Review 1.  Understanding the HPA response to critical illness: novel insights with clinical implications.

Authors:  Eva Boonen; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2014-11-19       Impact factor: 17.440

Review 2.  Sepsis: frontiers in supportive care, organisation and research.

Authors:  Anders Perner; Andrew Rhodes; Bala Venkatesh; Derek C Angus; Ignacio Martin-Loeches; Jean-Charles Preiser; Jean-Louis Vincent; John Marshall; Konrad Reinhart; Michael Joannidis; Steven M Opal
Journal:  Intensive Care Med       Date:  2017-01-27       Impact factor: 17.440

Review 3.  Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis.

Authors:  M Volbeda; J Wetterslev; C Gluud; J G Zijlstra; I C C van der Horst; F Keus
Journal:  Intensive Care Med       Date:  2015-06-23       Impact factor: 17.440

4.  Do low-dose corticosteroids improve survival or shock reversal from septic shock in adults? Meta-analysis with trial sequential analysis.

Authors:  Rui Xu; Qian Wang; Yan Huang; Ling Wu; Qi Liu; Wei Hu; Chengfu Zhou; Quan Du
Journal:  J Int Med Res       Date:  2018-06-18       Impact factor: 1.671

5.  Restrained expression of canine glucocorticoid receptor splice variants α and P prognosticates fatal disease outcome in SIRS.

Authors:  Brigitta Margit Kállai; Judit Csöndes; Gergely Kiss; Lilla Bodrogi; Zsolt Rónai; Tamás Mészáros
Journal:  Sci Rep       Date:  2021-12-30       Impact factor: 4.379

6.  Acute neuro-endocrine profile and prediction of outcome after severe brain injury.

Authors:  Zandra Olivecrona; Per Dahlqvist; Lars-Owe D Koskinen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-04-20       Impact factor: 2.953

7.  Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced Sepsis.

Authors:  Caiyi C Li; Ivana Munitic; Paul R Mittelstadt; Ehydel Castro; Jonathan D Ashwell
Journal:  PLoS Biol       Date:  2015-10-06       Impact factor: 8.029

8.  Understanding adrenal crisis.

Authors:  Karin Amrein; Gennaro Martucci; Stefanie Hahner
Journal:  Intensive Care Med       Date:  2017-10-26       Impact factor: 17.440

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.